Lassiter, G.; Bergeron, C.; Guedry, R.; Cucarola, J.; Kaye, A.M.; Cornett, E.M.; Kaye, A.D.; Varrassi, G.; Viswanath, O.; Urits, I.
Belantamab Mafodotin to Treat Multiple Myeloma: A Comprehensive Review of Disease, Drug Efficacy and Side Effects. Curr. Oncol. 2021, 28, 640-660.
https://doi.org/10.3390/curroncol28010063
AMA Style
Lassiter G, Bergeron C, Guedry R, Cucarola J, Kaye AM, Cornett EM, Kaye AD, Varrassi G, Viswanath O, Urits I.
Belantamab Mafodotin to Treat Multiple Myeloma: A Comprehensive Review of Disease, Drug Efficacy and Side Effects. Current Oncology. 2021; 28(1):640-660.
https://doi.org/10.3390/curroncol28010063
Chicago/Turabian Style
Lassiter, Grace, Cole Bergeron, Ryan Guedry, Julia Cucarola, Adam M. Kaye, Elyse M. Cornett, Alan D. Kaye, Giustino Varrassi, Omar Viswanath, and Ivan Urits.
2021. "Belantamab Mafodotin to Treat Multiple Myeloma: A Comprehensive Review of Disease, Drug Efficacy and Side Effects" Current Oncology 28, no. 1: 640-660.
https://doi.org/10.3390/curroncol28010063
APA Style
Lassiter, G., Bergeron, C., Guedry, R., Cucarola, J., Kaye, A. M., Cornett, E. M., Kaye, A. D., Varrassi, G., Viswanath, O., & Urits, I.
(2021). Belantamab Mafodotin to Treat Multiple Myeloma: A Comprehensive Review of Disease, Drug Efficacy and Side Effects. Current Oncology, 28(1), 640-660.
https://doi.org/10.3390/curroncol28010063
